checkAd
    Startseite > Aktien > Athersys > Nachrichten
    Athersys Aktie
    0,0045
     
    USD
    +4,65 %
    +0,0002 USD
    Letzter Kurs 02:10:00 Nasdaq OTC
    ISIN: US04744L2051 · WKN: A3DR6K · SYM: ATHXQ · USA

    Neueste Nachrichten

    Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives
    16.10.23 · Business Wire (engl.) · Athersys
    Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios
    10.10.23 · Business Wire (engl.) · Athersys
    Athersys Licenses its Animal Health Assets to Ardent Animal Health
    03.10.23 · Business Wire (engl.) · Athersys
    Athersys Director Jane Wasman Appointed Board Chair
    02.10.23 · Business Wire (engl.) · Athersys
    Grant Awarded to Newcastle University to Research Athersys’ MultiStem in Machine Perfusion Prior to Kidney Transplantation
    06.09.23 · Business Wire (engl.) · Athersys
    Athersys, Inc. Announces Pricing of $3.5 Million Public Offering
    18.08.23 · Business Wire (engl.) · Athersys
    Athersys Reports Second Quarter 2023 Financial Results and Business Highlights
    16.08.23 · Business Wire (engl.) · Athersys
    Athersys Appoints Neema Mayhugh, PhD to its Board of Directors
    11.08.23 · Business Wire (engl.) · Athersys
    Athersys to Host Business Update Conference Call on August 9th
    31.07.23 · Business Wire (engl.) · Athersys
    Patient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys’ MultiStem Following Hemorrhagic Trauma
    01.06.23 · Business Wire (engl.) · Athersys
    Athersys Restructures Debt with Supplier
    23.05.23 · Business Wire (engl.) · Athersys
    Athersys Reports First Quarter 2023 Financial Results and Business Highlights
    18.05.23 · Business Wire (engl.) · Athersys